Final Program

294 TUESDAY • MAY 17
P659
P660
P661
P662
P663
P664
P665
Facilitator:
P666
P667
P668
P669
P670
P671
Can Information from Cardiopulmonary Exercise Testing
Predict Outcome After Pulmonary Rehabilitation in Patients
with COPD?/R.J. Perez, R. ZuWallack, D. Datta, Farmington, CT,
p.A5731
Comorbidities in Patients with Chronic Obstructive Pulmonary
Disease and Pulmonary Rehabilitation Outcomes/P. Tunsupon,
A. Lal, M.A. Khamis, M.J. Mador, Buffalo, NY, p.A5732
Short Duration Dyspnea Challenge Test to Assess Severity of
Dyspnea in Patients with Chronic Obstructive Pulmonary
Disease/P. Sharma, N.R. Morris, M. Sabaratnam, L. Adams,
Southport, Australia, p.A5733
Chronic Obstructive Pulmonary Disease (COPD) Patients After
Pulmonary Rehab: Psycho-Social Factors/M. Dekker, P. Saini,
R. Priori, C. Barretto, M. Sillen, M. Spruit, Eindhoven, Netherlands,
p.A5734
Clinical, Socio-Demographic and Psychological
Characteristics of Participants and Non-Participants to
Pulmonary Rehabilitation in Patients with Chronic Obstructive
Pulmonary Disease (COPD)/E.D. Rivard, V. Pepin, F. Beaucage,
L. Blais, G. Moullec, RESP Team, Montreal, Canada, p.A5735
Trends of Symptom Scores in COPD Patients Followed in a
Tertiary Care Pulmonology Clinic: Are Patients Feeling
Better?/R. Evans, N. Menon, C.S. Tsai, S.A. Evans, D.W. Drumm,
A.L. Berger, P.F. Simonelli, Danville, PA, p.A5736
Pulmonary Rehabilitation Is Associated with Improvement in
Short Physical Performance Battery Scores in COPD/C.
Teneback, P. Savage, Burlington, VT, p.A5737
H. Demeyer, PhD, Leuven, Belgium
Postural Deviations in People with Chronic Obstructive
Pulmonary Disease (COPD)/A.L. Lee, K. Zabjek, R.S. Goldstein,
D. Brooks, Toronto, Canada, p.A5738
“Who Wants to Hurt?” - A Qualitative Exploration of Pain
Experiences and Their Meaning in People with Chronic
Obstructive Pulmonary Disease (COPD)/A.L. Lee, S.L. Harrison,
R.S. Goldstein, D. Brooks, Toronto, Canada, p.A5739
Chronic Pain in Chronic Obstructive Pulmonary Disease
(COPD): Prevalence, Clinical Implications and Psychological
Responses/A.L. Lee, R.S. Goldstein, D. Brooks, Toronto, Canada,
p.A5740
Light Intensity Physical Activity (LIPA) Is Associated with
Patient Reported Outcomes in People with COPD/N.S. Cox,
A.T. Burge, A. Mahal, C.J. Hill, A.L. Lee, R. Moore, C. Nicolson, A.
Lahham, R. Ndongo, C.F. McDonald, A.E. Holland, Melbourne,
Australia, p.A5741
The Minimal Clinically Important Difference for Daily Step
Counts in Persons with COPD/M. Teylan, D. Homsy, O. Okunbur,
J. Gao, E. Garshick, M.L. Moy, Boston, MA, p.A5742
Objectively Measured Sedentary Behavior in People with
COPD and Assisted Living Residents/J.L. Larson, C. Vos, S.
Woo, D. Fernandez, D. Buckery, Ann Arbor, MI, p.A5743
P672
P673
C67
Objectively Measured Physical Activity and Sleep Quality in
Chronic Obstructive Pulmonary Disease/Z. Parwanta, A.T.
Burge, V. Pepin, N.S. Cox, A.E. Holland, Montreal, Canada,
p.A5744
A Screening Tool to Predict Obstructive Sleep Apnea in
Patients with Chronic Obstructive Pulmonary Disease: A Pilot
Study of the UCSD COPD-OSA Questionnaire/X. Soler, S.-Y.
Liao, A.L. Ries, A. Malhotra, San Diego, CA, p.A5745
THEMATIC POSTER SESSION
ACUTE LUNG INJURY
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area M, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1475
P1476
P1477
P1478
P1479
Facilitator:
P1480
P1481
L.G. Dobbs, MD, Oakland, CA
Altered Expression of IRF1 and Its Regulatory Genes in
Lipopolysaccharide-Induced Acute Lung Injury Mouse
Model/J.-R. Park, H. Lee, S.-R. Yang, Chuncheon, Korea, Republic
of, p.A5746
F Box Protein FBXO10 Targets the Receptor for Advanced
Glycation End Products (RAGE) for Ubiquitination and
Degradation in Human Bronchial Epithelial Cells/J. Evankovich,
S. Dunn, A. Mckelvey, T. Lear, B.B. Chen, R. Mallampalli,
Pittsburgh, PA, p.A5747
Attenuation of Lung Injury by Lung Epithelium Cell Specific
Knockdown of Nampt Gene Expression/G. Bi, N.N. Nsumu, L.
Zhang, D. Heruth, S. Ye, Kansas City, MO, p.A5748
Epithelial Cells Internalize Macrophage-Derived Microparticles:
Mechanisms of Uptake and Modulation by the Extracellular
Environment/D.J. Schneider, J.M. Speth, L.R.K. Penke, M.
Peters-Golden, Ann Arbor, MI, p.A5749
Deletion of aENaC in Alveolar Type I Cells Demonstrates the
Integral Role of Type I Cells in Maintaining Lung Fluid
Balance/M. Johnson, S. Balan, A.M. Gillespie, L. Dobbs, San
Francisco, CA, p.A5750
G.M. Mutlu, MD, Chicago, IL
AKB-9785, a VE-PTP Inhibitor, Decreases Inflammation and
Alters the Angiopoietin/Tie2 System Dynamic Response in a S.
Aureus Sepsis Model/R.R. Bartz, T. McCord, H. Suliman, T. Orr,
C.A. Piantadosi, C. Kontos, Durham, NC, p.A5751
Differential Pulmonary Gene and Protein Expression in Wild
Type, Cyp1a1-Null and Cyp1a2-Null Mice in Acute Hyperoxic
Lung Injury: Role of Cytochrome P450 (CYP)1A/K. Lingappan,
S. Maity, W. Jiang, L. Wang, X. Couroucli, C. Coarfa, B. Moorthy,
Houston, TX, p.A5752
ATS 2016 • San Francisco